FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Masanori Noguchi

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Procedures

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Masanori Noguchi; Tetsuro Sasada; Kyogo Itoh
Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine.
Akira Yamada; Masanori Noguchi; Tetsuro Sasada; Kyogo Itoh
Next-generation peptide vaccines for advanced cancer.
Kyogo Itoh; Ryuji Takahashi; Mizuhiko Terasaki; Munehiro Yoshitomi; Masanori Noguchi
[Personalized peptide vaccination].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Masanori Noguchi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Masanori Noguchi; Tetsuro Sasada; Kyogo Itoh
Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine.
Cancer immunology, immunotherapy : CII 2013;62(5):919-29.
2013: Akira Yamada; Masanori Noguchi; Tetsuro Sasada; Kyogo Itoh
Next-generation peptide vaccines for advanced cancer.
Cancer science 2013;104(1):15-21.
2012: Kyogo Itoh; Ryuji Takahashi; Mizuhiko Terasaki; Munehiro Yoshitomi; Masanori Noguchi
[Personalized peptide vaccination].
Nihon rinsho. Japanese journal of clinical medicine 2012;70(12):2118-23.
2012: Tetsuro Sasada; Akira Yamada; Masanori Noguchi; Kyogo Itoh
Personalized peptide vaccination: a novel immunotherapeutic approach for advanced cancer.
Human vaccines & immunotherapeutics 2012;8(9):1309-13.
2012: Nobukazu Komatsu; Satoru Kuhara; Satoko Matsueda; Kei Matsuoka; Fukuko Moriya; Masanori Noguchi; Shigeki Shichijo; Shigetaka Suekane; Kousuke Tashiro; Akira Yamada; Atsushi Doi; Tetsuya Ioji; Kyogo Itoh; Tetsuro Sasada
Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination.
Cancer 2012;118(12):3208-21.
2011: Masanori Noguchi; Hirotsugu Uemura; Seiji Naito; Hideyuki Akaza; Akira Yamada; Kyogo Itoh
A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer.
The Prostate 2011;71(5):470-9.
2011: Kazumi Yoshida; Masanori Noguchi; Takashi Mine; Nobukazu Komatsu; Shigeru Yutani; Takato Ueno; Hiroaki Yanagimoto; Kouichirou Kawano; Kyogo Itoh; Akira Yamada
Characteristics of severe adverse events after peptide vaccination for advanced cancer patients: Analysis of 500 cases.
Oncology reports 2011;25(1):57-62.
2010: Kanako Iseki; Hiromi Matsunaga; Nobukazu Komatsu; Shigetaka Suekane; Masanori Noguchi; Kyogo Itoh; Akira Yamada
Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination.
Cancer science 2010;101(10):2110-4.
2010: Masanori Noguchi; Tatsuyuki Kakuma; Hirotsugu Uemura; Yasutomo Nasu; Hiromi Kumon; Yasuhiko Hirao; Fukuko Moriya; Shigetaka Suekane; Kei Matsuoka; Nobukazu Komatsu; Shigeki Shichijo; Akira Yamada; Kyogo Itoh
A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.
Cancer immunology, immunotherapy : CII 2010;59(7):1001-9.
2010: Tetsuro Sasada; Nobukazu Komatsu; Shigetaka Suekane; Akira Yamada; Masanori Noguchi; Kyogo Itoh
Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines.
European journal of cancer (Oxford, England : 1990) 2010;46(9):1514-9.
2009: Yasunobu Terasaki; Shigeki Shichijo; Yamei Niu; Nobukazu Komatsu; Masanori Noguchi; Satoru Todo; Kyogo Itoh
An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 alleles.
Cancer immunology, immunotherapy : CII 2009;58(11):1877-85.
2009: Elnisr Rashed Mohamed; Masayasu Naito; Yasuhiro Terasaki; Yamei Niu; Shojiro Gohara; Nobukazu Komatsu; Shigeki Shichijo; Kyogo Itoh; Masanori Noguchi
Capability of SART3(109-118) peptide to induce cytotoxic T lymphocytes from prostate cancer patients with HLA class I-A11, -A31 and -A33 alleles.
International journal of oncology 2009;34(2):529-36.
2009: Kyogo Itoh; Akira Yamada; Takashi Mine; Masanori Noguchi
Recent advances in cancer vaccines: an overview.
Japanese journal of clinical oncology 2009;39(2):73-80.
2008: Masayasu Naito; Kyogo Itoh; Nobukazu Komatsu; Yuichi Yamashita; Takafumi Shirakusa; Akira Yamada; Fukuko Moriya; Hitoshi Ayatuka; Elnisr Rashed Mohamed; Kei Matsuoka; Masanori Noguchi
Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients.
The Prostate 2008;68(16):1753-62.
2008: Masanori Noguchi; Tatsuyuki Kakuma; Shigetaka Suekane; Osamu Nakashima; Elnisr Rashed Mohamed; Kei Matsuoka
A randomized clinical trial of suspension technique for improving early recovery of urinary continence after radical retropubic prostatectomy.
BJU international 2008;102(8):958-63.
2008: Masanori Noguchi; Tatsuyuki Kakuma; Katsuro Tomiyasu; Akira Yamada; Kyogo Itoh; Fumiko Konishi; Shoichiro Kumamoto; Kuniyoshi Shimizu; Ryuichiro Kondo; Kei Matsuoka
Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms.
Asian journal of andrology 2008;10(5):777-85.
2008: Masanori Noguchi; Tatsuyuki Kakuma; Katsuro Tomiyasu; Yoshiko Kurita; Hiroko Kukihara; Fumiko Konishi; Shoichiro Kumamoto; Kuniyoshi Shimizu; Ryuichiro Kondo; Kei Matsuoka
Effect of an extract of Ganoderma lucidum in men with lower urinary tract symptoms: a double-blind, placebo-controlled randomized and dose-ranging study.
Asian journal of andrology 2008;10(4):651-8.
2008: Makoto Nakiri; Masanori Noguchi; Tatsuya Ishitake; Kei Matsuoka
Bilateral neurovascular bundles sparing prostatectomy preserves sexual function in patients with localized prostate cancer.
The Kurume medical journal 2008;55(3-4):63-9.
2007: M Naito; Yoshihiro Komohara; Yuki Ishihara; Masanori Noguchi; Y Yamashita; T Shirakusa; Akira Yamada; Kyogo Itoh; Mine Harada
Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles.
British journal of cancer 2007;97(12):1648-54.
2007: Yoshihiro Komohara; Mamoru Harada; Yuki Ishihara; Shigetaka Suekane; Masanori Noguchi; Akira Yamada; Kei Matsuoka; Kyogo Itoh
HLA-G as a target molecule in specific immunotherapy against renal cell carcinoma.
Oncology reports 2007;18(6):1463-8.
2007: Shigetaka Suekane; Masa-aki Nishitani; Masanori Noguchi; Yoshihiro Komohara; Takako Kokubu; Masayasu Naitoh; Shigenori Honma; Akira Yamada; Kyogo Itoh; Kei Matsuoka; Hiro-Omi Kanayama
Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients.
Cancer science 2007;98(12):1965-8.
2007: Yukoh Itoh; Yoshihiro Komohara; Nobukazu Komatsu; Takafumi Minami; Koujiro Saito; Masanori Noguchi; Kyogo Itoh; Mamoru Harada
New peptides of the polycomb group protein enhancer of zeste homolog 2 with the potential to induce cancer-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ prostate cancer patients.
Oncology reports 2007;18(5):1231-7.
2007: Shigetaka Suekane; Masanori Noguchi; Osamu Nakashima; Satoko Yamada; Masamichi Kojiro; Kei Matsuoka
Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
International journal of urology : official journal of the Japanese Urological Association 2007;14(8):713-8.
2007: Shigenori Homma; Yoshihiro Komohara; Mamoru Harada; Hideyuki Saya; Satoru Todo; Kyogo Itoh; Masanori Noguchi
Differential levels of human leukocyte antigen-class I, multidrug-resistance 1 and androgen receptor expressions in untreated prostate cancer cells: the robustness of prostate cancer.
Oncology reports 2007;18(2):343-6.
2007: Masanori Noguchi; Akihisa Yao; Mamoru Harada; Osamu Nakashima; Yoshihiro Komohara; Satoko Yamada; Kyogo Itoh; Kei Matsuoka
Immunological evaluation of neoadjuvant peptide vaccination before radical prostatectomy for patients with localized prostate cancer.
The Prostate 2007;67(9):933-42.
2007: Takafumi Minami; Satoko Matsueda; Hiroko Takedatsu; Masahiro Tanaka; Masanori Noguchi; Hirotsugu Uemura; Kyogo Itoh; Mamoru Harada
Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles.
Cancer immunology, immunotherapy : CII 2007;56(5):689-98.
2007: Yoshihiro Komohara; Mamoru Harada; Yoshimi Arima; Shigetaka Suekane; Masanori Noguchi; Akira Yamada; Kyogo Itoh; Kei Matsuoka
Identification of target antigens in specific immunotherapy for renal cell carcinoma.
The Journal of urology 2007;177(3):1157-62.
2007: Masanori Noguchi; Takashi Mine; Akira Yamada; Yayoi Obata; Kazumi Yoshida; Junko Mizoguchi; Mamoru Harada; Shigetaka Suekane; Kyogo Itoh; Kei Matsuoka
Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment.
Oncology research 2007;16(7):341-9.
2007: Yoshihiro Komohara; Shigetaka Suekane; Masanori Noguchi; Kei Matsuoka; Akira Yamada; Kyogo Itoh
Expression of APOBEC3G in kidney cells.
Tissue antigens 2007;69(1):95-8.
2006: Yoshihiro Komohara; Mamoru Harada; Yoshimi Arima; Shigetaka Suekane; Masanori Noguchi; Akira Yamada; Kyogo Itoh; Kei Matsuoka
Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinoma.
International journal of oncology 2006;29(6):1555-60.
2006: Shigenori Homma; Masanori Noguchi; Yuji Sato; Yoshiaki Maeda; Hiroki Shomura; Yoshihiro Komohara; Takashi Mine; Mamoru Harada; Akira Yamada; Satoru Todo; Kyogo Itoh
[Acquired tumor "robustness" in the case of prostate cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33(12):1748-50.
2006: Masanori Noguchi; Kei Matsuoka; Hirofumi Koga; Hiroshi Kanetake; Masayuki Nakagawa; Seiji Naito
A questionnaire survey of patient preparation and techniques for prostate biopsy among urologists in the Kyushu and Okinawa regions of Japan.
International journal of clinical oncology 2006;11(5):390-5.
2006: Masanori Noguchi; Daisuke Deguchi; Junichiro Toriwaki; Kensaku Mori; Yoshito Mekada; Kei Matsuoka
Evaluation of a prostate biopsy strategy for cancer detection using a computer simulation system with virtual needle biopsy for three-dimensional prostate models.
International journal of urology : official journal of the Japanese Urological Association 2006;13(10):1296-303.
2006: Masanori Noguchi; Akihiko Shimada; Osamu Nakashima; Masamichi Kojiro; Kei Matsuoka
Urodynamic evaluation of a suspension technique for rapid recovery of continence after radical retropubic prostatectomy.
International journal of urology : official journal of the Japanese Urological Association 2006;13(4):373-8.
2005: Satoko Matsueda; Hiroko Takedatsu; Akihisa Yao; Masahiro Tanaka; Masanori Noguchi; Kyogo Itoh; Mamoru Harada
Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 1):6933-43.
2005: Mamoru Harada; Satoko Matsueda; Akihisa Yao; Masanori Noguchi; Kyogo Itoh
Vaccination of cytotoxic T lymphocyte-directed peptides elicited and spread humoral and Th1-type immune responses to prostate-specific antigen protein in a prostate cancer patient.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(4):368-75.
2005: Masanori Noguchi; Kyogo Itoh; Akihisa Yao; Takashi Mine; Akira Yamada; Yayoi Obata; Masatoshi Furuta; Mamoru Harada; Shigetaka Suekane; Kei Matsuoka
Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patients.
The Prostate 2005;63(1):1-12.
2005: Akihisa Yao; Mamoru Harada; Satoko Matsueda; Yuki Ishihara; Hiroki Shomura; Yukari Takao; Masanori Noguchi; Kei Matsuoka; Isao Hara; Sadao Kamidono; Kyogo Itoh
New epitope peptides derived from parathyroid hormone-related protein which have the capacity to induce prostate cancer-reactive cytotoxic T lymphocytes in HLA-A2+ prostate cancer patients.
The Prostate 2005;62(3):233-42.
2004: Masanori Noguchi; Akihiko Shimada; Jyunro Yahara; Shigetaka Suekane; Shinshi Noda
Early catheter removal 3 days after radical retropubic prostatectomy.
International journal of urology : official journal of the Japanese Urological Association 2004;11(11):983-8.
2004: Mamoru Harada; Satoko Matsueda; Akihisa Yao; Rika Ogata; Masanori Noguchi; Kyogo Itoh
Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2+ prostate cancer patients.
Oncology reports 2004;12(3):601-7.
2004: Rika Ogata; Satoko Matsueda; Akihisa Yao; Masanori Noguchi; Kyogo Itoh; Mamoru Harada
Identification of polycomb group protein enhancer of zeste homolog 2 (EZH2)-derived peptides immunogenic in HLA-A24+ prostate cancer patients.
The Prostate 2004;60(4):273-81.
2004: Satoko Matsueda; Akihisa Yao; Yuki Ishihara; Rika Ogata; Masanori Noguchi; Kyogo Itoh; Mamoru Harada
A prostate stem cell antigen-derived peptide immunogenic in HLA-A24- prostate cancer patients.
The Prostate 2004;60(3):205-13.
2004: Akihisa Yao; Mine Harada; Satoko Matsueda; Yuki Ishihara; Hiroki Shomura; Masanori Noguchi; Kei Matsuoka; I Hara; Sadao Kamidono; Kyogo Itoh
Identification of parathyroid hormone-related protein-derived peptides immunogenic in human histocompatibility leukocyte antigen-A24+ prostate cancer patients.
British journal of cancer 2004;91(2):287-96.
2004: Masanori Noguchi; Kyogo Itoh; Shigetaka Suekane; Akiko Morinaga; Aki Sukehiro; Norie Suetsugu; Kazuko Katagiri; Akira Yamada; Shinshi Noda
Immunological monitoring during combination of patient-oriented peptide vaccination and estramustine phosphate in patients with metastatic hormone refractory prostate cancer.
The Prostate 2004;60(1):32-45.
2004: Satoko Matsueda; Kazuhiko Kobayashi; Yoichi Nonaka; Masanori Noguchi; Kyogo Itoh; Mamoru Harada
Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2(+) patients with hormone-refractory prostate cancer.
Cancer immunology, immunotherapy : CII 2004;53(6):479-89.
2004: Takashi Mine; Yuji Sato; Masanori Noguchi; Teruo Sasatomi; Rumi Gouhara; Naotake Tsuda; Shoko Tanaka; Hiroki Shomura; Kazuko Katagiri; Toru Rikimaru; Shigeki Shichijo; Toshiharu Kamura; Takashi Hashimoto; Kazuo Shirouzu; Akira Yamada; Satoru Todo; Kyogo Itoh; Hideaki Yamana
Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):929-37.
2004: Masanori Noguchi; Shinshi Noda; Masaki Yoshida; Shoichi Ueda; Taizo Shiraishi; Kyogo Itoh
Chemohormonal therapy as primary treatment for metastatic prostate cancer: a randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist.
International journal of urology : official journal of the Japanese Urological Association 2004;11(2):103-9.
2004: Masanori Noguchi; Shinshi Noda; Osamu Nakashima; Kei Matsuoka; Masamichi Kojiro
Suspension technique improves rapid recovery of urinary continence following radical retropubic prostatectomy.
The Kurume medical journal 2004;51(3-4):245-51.
2004: Masanori Noguchi; Kyogo Itoh; Shigetaka Suekane; Akihisa Yao; Norie Suetsugu; Kazuko Katagiri; Akira Yamada; Hideaki Yamana; Shinshi Noda
Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer.
Cancer science 2004;95(1):77-84.
2003: Mamoru Harada; Kazuhiko Kobayashi; Satoko Matsueda; Masami Nakagawa; Masanori Noguchi; Kyogo Itoh
Prostate-specific antigen-derived epitopes capable of inducing cellular and humoral responses in HLA-A24+ prostate cancer patients.
The Prostate 2003;57(2):152-9.
2003: Masanori Noguchi; Kazuhiko Kobayashi; Norie Suetsugu; Katsuro Tomiyasu; Shigetaka Suekane; Akira Yamada; Kyogo Itoh; Shinshi Noda
Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination.
The Prostate 2003;57(1):80-92.
2003: Jyunro Yahara; Masanori Noguchi; Shinshi Noda
Quantitative evaluation of bone metastases in patients with advanced prostate cancer during systemic treatment.
BJU international 2003;92(4):379-83; discussion 383-4.
2003: Mamoru Harada; Masanori Noguchi; Kyogo Itoh
Target molecules in specific immunotherapy against prostate cancer.
International journal of clinical oncology 2003;8(4):193-9.
2003: Masanori Noguchi; Thomas A Stamey; John E McNeal; Rosalie Nolley
Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers.
The Journal of urology 2003;170(2 Pt 1):459-63.
2003: Shoko Tanaka; Mamoru Harada; Takashi Mine; Masanori Noguchi; Rumi Gohara; Koichi Azuma; Mayumi Tamura; Akira Yamada; Akiko Morinaga; Misa Nishikori; Kazuko Katagiri; Kyogo Itoh; Hideaki Yamana; Takashi Hashimoto
Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific ctotoxic T-lymphocyte precursors in the periphery.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2003;26(4):357-66.
2003: Kazuhiko Kobayashi; Masanori Noguchi; Kyogo Itoh; Mamoru Harada
Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24+ prostate cancer patients.
Cancer science 2003;94(7):622-7.
2003: Masanori Noguchi; Jyunro Yahara; Shinshi Noda
Serum levels of bone turnover markers parallel the results of bone scintigraphy in monitoring bone activity of prostate cancer.
Urology 2003;61(5):993-8.
2003: Masanori Noguchi; H Kikuchi; M Ishibashi; S Noda
Percentage of the positive area of bone metastasis is an independent predictor of disease death in advanced prostate cancer.
British journal of cancer 2003;88(2):195-201.
2003: Masanori Noguchi; Jyunro Yahara; Teruo Motomori; Shinshi Noda
Transurethral electrovaporization for giant prostatic hyperplasia: report of a case.
The Kurume medical journal 2003;50(3-4):151-3.
2002: Masanori Noguchi; Yasuo Hirabayashi; Seiya Kato; Shinshi Noda
Solitary fibrous tumor arising from the prostatic capsule.
The Journal of urology 2002;168(4 Pt 1):1490-1.
2002: Masanori Noguchi; Shinshi Noda; Osamu Nakashima; Masamichi Kojiro
No residual tumor in a radical prostatectomy specimen after neoadjuvant hormonal therapy for localized prostate cancer.
Oncology reports 2002;9(5):1075-80.
2001: Masanori Noguchi; Shinshi Noda
Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer.
The Journal of urology 2001;166(3):1106-10.
2001: H Kikuchi; Masanori Noguchi; Hidetoshi Akashi; Shinshi Noda
Spontaneous shunt between the superior mesenteric vein and the right renal vein caused by portal hypertension.
The Journal of urology 2001;165(5):1615-6.
1999: Masanori Noguchi; Jyunro Yahara; H Koga; Osamu Nakashima; Shinshi Noda
Necessity of repeat biopsies in men for suspected prostate cancer.
International journal of urology : official journal of the Japanese Urological Association 1999;6(1):7-12.
1997: Masanori Noguchi; Y Eguchi; J Ichiki; Jyunro Yahara; Shinshi Noda
Therapeutic efficacy of clenbuterol for urinary incontinence after radical prostatectomy.
International journal of urology : official journal of the Japanese Urological Association 1997;4(5):480-3.
1997: Masanori Noguchi; J Miyajima; Kyogo Itoh; Shinshi Noda
Detection of circulating tumor cells in patients with prostate cancer using prostate specific membrane-derived primers in the polymerase chain reaction.
International journal of urology : official journal of the Japanese Urological Association 1997;4(4):374-9.